Search
Showing results for "1"
News & Events
Community forum and symposium a big successThe Children’s Diabetes Centre was honoured to have leading international experts Laurel Messer and Professor Mike Riddell as guest speakers at its community forum and research symposium recently.
News & Events
Seed Funding GrantsThe Rio Tinto Children's Diabetes Centre; a Breakthrough T1D Centre of Excellence is excited the announce the latest round of seed funding recipients.
News & Events
World Diabetes DayIt may only have been a matter of months since Abby Carlon was diagnosed with type 1 diabetes but already the 10-year-old knows more than most about the condition. That’s because she’s always kept an eye out for her little sister Mia who was diagnosed with type 1 diabetes when she was three.
Research
Genomic responses during acute human anaphylaxis are characterized by upregulation of innate inflammatory gene networksThe aim of this study was to examine the gene response of white blood cells in severe allergic reactions to identify genes that could be targets to new drugs...
Research
Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucoseThe objective of this study was to determine whether real-time continuous glucose monitoring (CGM) with preset alarms at specific glucose levels would prove...
Thanks for being part of the ORIGINS Facebook group! See our favourite iron rich recipes below.
News & Events
Student ScholarshipsThe Centre aims to improve the lives of young people living with diabetes by encouraging new and innovative research, researchers and translation
News & Events
Hybrid-Closed loop system improves quality of lifeNew Insulin delivery technology improves quality of life and offers better glucose control in young people living with type 1 diabetes.
Research
"i Think i Could Have Used It Better": Experiences of Youth with High HbA1c Commencing Advanced Hybrid Closed-Loop Therapy in a Clinical Trial Setting - A Qualitative ResearchAdvanced hybrid closed-loop (AHCL) therapy improves glycemia. However, it is not known if there is an improvement in overall outcomes with AHCL for youth with type 1 diabetes (T1D) at high risk of diabetes-related complications. The study aimed to capture the experiences of youth with suboptimal glycemic control when commencing AHCL therapy in a clinical trial setting.